|
HY-139602-100mg
|
MedChemexpress LLC
|
(+)-JNJ-A07 [CAS 2135640-93-4]
|
|
COVID-19-anti-virus
|
|
|
HY-139602-25mg
|
MedChemexpress LLC
|
(+)-JNJ-A07 [CAS 2135640-93-4]
|
|
COVID-19-anti-virus
|
|
|
HY-139602-5mg
|
MedChemexpress LLC
|
(+)-JNJ-A07 [CAS 2135640-93-4]
|
|
COVID-19-anti-virus
|
|
|
HY-139602-50mg
|
MedChemexpress LLC
|
(+)-JNJ-A07 [CAS 2135640-93-4]
|
|
COVID-19-anti-virus
|
|
|
HY-139602-1mL
|
MedChemexpress LLC
|
(+)-JNJ-A07 [CAS 2135640-93-4] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-14808-10mg
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14808-5mg
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14808-50mg
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14808-1mL
|
MedChemexpress LLC
|
Adarotene [CAS 496868-77-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-108645-5mg
|
MedChemexpress LLC
|
AL 8697 [CAS 1057394-06-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108645-1mL
|
MedChemexpress LLC
|
AL 8697 [CAS 1057394-06-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-147349-10mg
|
MedChemexpress LLC
|
ANT3310 (sodium) [CAS 2410688-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-147349-100mg
|
MedChemexpress LLC
|
ANT3310 (sodium) [CAS 2410688-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-147349-25mg
|
MedChemexpress LLC
|
ANT3310 (sodium) [CAS 2410688-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-147349-5mg
|
MedChemexpress LLC
|
ANT3310 (sodium) [CAS 2410688-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-147349-50mg
|
MedChemexpress LLC
|
ANT3310 (sodium) [CAS 2410688-61-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-147349-1mL
|
MedChemexpress LLC
|
ANT3310 (sodium) [CAS 2410688-61-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N6842-1mg
|
MedChemexpress LLC
|
ArnicolideC [CAS 34532-67-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6842-5mg
|
MedChemexpress LLC
|
ArnicolideC [CAS 34532-67-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1682A-25mg
|
MedChemexpress LLC
|
Balixafortide (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1682A-5mg
|
MedChemexpress LLC
|
Balixafortide (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-P1682A-50mg
|
MedChemexpress LLC
|
Balixafortide (TFA)
|
|
Cancer-programmed cell death
|
|
|
HY-W107024-1mg
|
MedChemexpress LLC
|
BMS-986260 [CAS 2001559-19-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-13266-10mg
|
MedChemexpress LLC
|
BS-181 [CAS 1092443-52-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13266-5mg
|
MedChemexpress LLC
|
BS-181 [CAS 1092443-52-1]
|
|
Cancer-Kinase/protease
|
|
